About IQVIA Africa

The IQVIATM team in Africa provides tools and resources to enable clients to succeed in the competitive and changing environment with distinct regional nuances. We help clients improve performance and minimize marketplace risk through superior forecasting and trend analysis, real world evidence studies, and technology and commercial effectiveness solutions. Our market intelligence and consulting expertise give you the critical facts you need at every step—from the earliest stages of research and development through product launch, product maturation, and patent expiration.

We understand the African healthcare market—and your issues. We can help you ask the right questions and craft customized solutions through a unique continuum of unmatched information, analytics, and technology solutions working together seamlessly.

It’s bigger than better clinical trials. Or advances in technologies and analytics. Or faster insights. It’s about unleashing the power of human data science. And that is why IMS Health and Quintiles have come together to be IQVIA, The Human Data Science Company.

Learn more about IQVIA

Let’s Talk Oncology: Pharma in the Middle East

April 10 at 11:30

Contact Us

Clinical & Commercial Nigeria Limited
1st Floor, Plot 2-4, Block-D
Amuwo Odofin Industrial Scheme
Apapa Oshodi Expressway
Lagos, Nigeria

West Africa Ltd
Kajima Building
College of Health Sciences
University of Ghana, Legon- Accra

Résidence "la Baie du Lac"
2nd Floor, Cité les Pins
1053 Les Berges du Lac II - Tunis

Cité Sellier
Coopérative Immobilière Mohamed
Boudiaf N°18
1er étage
Hydra, Alger

Solis Premium Serviced Office Suites
6th Floor, West End Towers
Waiyaki Way, Westlands
P.O. Box 1896-00606 Sarit
Nairobi, Kenya


Osteoporosis in the Kingdom Of Saudi Arabia

Epidemiology and Associated Economic Costs
Worldwide, the prevalence of osteoporosis, and hence the incidence of related fractures, is high, especially due to aging populations. Osteoporotic fractures frequently require inpatient care.

Oncology in the Middle East Market

Continued Growth Expected
The global oncology market is expected to continue growing at 9% between 2016 and 2021, one of the highest forecasted growth rates. The focus on oncology will remain high over the next decade as pharma companies continue to invest resources and efforts.

Middle East and Africa Pharmaceutical Market

Quarterly Insights Report
The seventh edition of our quarterly market report covers a broad region from Middle East, North Africa, French West Africa and South Africa for the period of MAT Q3 2013 to MAT Q3 2017. This report will provide you with an overview of the market dynamics in terms of size, growth, therapy area and competitive landscape.